An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...
4h
News Medical on MSNResearchers develop mouse model to study neutrophilic asthmaA better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system.
Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.
5don MSN
John B. Amos Cancer Center at Piedmont Columbus Regional ’s midtown medical complex is the first in Georgia to offer this ...
6d
News Medical on MSNMAGE-4 promotes tumor progression by halting antitumor responsesA study published in Science Advances reveals a novel strategy that allows tumors to evade the body’s immune response ...
Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") reports continued favorable efficacy results from the 10-month follow-up visit for the fourth patient enrolled in its Deltacel-01 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results